A novel study — led by University of California San Diego and UCLA, in collaboration with the La Jolla Institute for Immunology — is assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.
مدينة روتشستر، ولاية مينيسوتا- بينما تتجمع العائلات لقضاء العطلات، من المهم للمرضى الذين يعانون من نقص المناعة اتخاذ خطوات إضافية للمساعدة في حماية أنفسهم من فيروس كورونا المستجد (كوفيد-19). الأشخاص المصابون بضعف في جهاز المناعة عرضة بشكل أكبر لخطر المرض الشديد جرَّاء فيروس كورونا المستجد (كوفيد-19
Conforme as famílias se reúnem para as festas de final de ano, é importante que os pacientes imunocomprometidos tomem medidas extras para ajudar a se proteger da COVID-19. Pessoas com o sistema imunológico enfraquecido correm maior risco de adoecer gravemente com a COVID-19.
Dada la proximidad de las reuniones familiares para celebrar las festividades, es importante que los pacientes con compromiso inmunitario tomen medidas adicionales para protegerse contra la COVID-19.
New research suggests there may someday be a role for ibuprofen in providing older adults with lasting immunity against RSV, a virus commonly associated with infants and young kids that also rivals the flu as a dangerous wintertime infection for the elderly.
El alergista Mark Corbett, MD, de Louisville, KY, fue designado como presidente del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) en la Reunión científica anual del ACAAI el 8 de noviembre en Nueva Orleans.
As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming infected with COVID-19. People who are immunocompromised have weakened immune systems, which means they have a higher risk of becoming severely ill from COVID-19.
Johns Hopkins researchers identified two distinct clusters of patients with PN: those who had increased inflammation in the blood, and those who did not but were more likely to have a history of spinal disease, which may sensitize the nerves. Identifying those with unique types of inflammation may help doctors provide more precise and personalized treatment for the disorder.
Allergist Mark Corbett, MD, of Louisville, KY, was installed as president of the American College of Allergy, Asthma and Immunology at the ACAAI Annual Scientific Meeting on November 8 in New Orleans.
Université de Montréal chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.
• People who are on dialysis or who have undergone kidney transplantation have immune system–related differences compared with people with normal kidney function, and these differences are further amplified by SARS-CoV-2 infection.
• The findings may help explain why these individuals face a higher risk of dying from COVID-19.
• Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
Stress can have a significant negative effect on health, but our understanding of how stress impacts the development and progression of cancer is just beginning. A team from Roswell Park Comprehensive Cancer Center has identified an important mechanism by which chronic stress weakens immunity and promotes tumor growth. Their findings, just published in Cell Reports, point to the beta-adrenergic receptor (β-AR) as a driver of immune suppression and cancer growth in response to stress, opening the possibility of targeting this receptor in cancer therapy and prevention.
It’s common for people with psoriasis to develop dry, inflamed skin lesions. But researchers found specific gene expression changes in healthy-appearing skin were a better predictor of clinical response to etanercept, an anti-TNF treatment prescribed to up to one-fifth of psoriasis patients. They say finding predictive signs in a patient’s genetic profile is a step toward applying precision medicine to complex inflammatory skin diseases.
A new study being presented at this year’s ACAAI Annual Scientific Meeting followed 5,874 kids with asthma in Los Angeles for 15 years and found no increase in allergic sensitizations.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año mostró que la mayoría de las mujeres embarazadas con una etiqueta de alergia a la penicilina a las que se les hizo la prueba no eran alérgicas y podían tolerar la penicilina durante el parto.
Un nuevo caso médicamente difícil presentado en la Reunión Científica Anual del ACAAI de este año informa de una situación en la que un medicamento antinflamatorio no esteroideo (AINE) causó una reacción anafiláctica en una maratonista.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la incorporación temprana del huevo está asociada con una menor probabilidad de tener alergia al huevo.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la población latina con asma tenían 4.6 veces más probabilidad que la población negra de presentar exacerbaciones del asma (asma no controlada) después de la COVID-19 y 2.9 veces más probabilidad que la población blanca.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la mayoría de los adultos encuestados no recibió preparación suficiente para su transición de parte de sus proveedores de la salud de asma infantil.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año hizo un seguimiento de 5874 niños con asma en Los Ángeles durante 15 años y descubrió que no hubo un aumento de las sensibilizaciones alérgicas.
Dos nuevos estudios que se presentan en la Reunión científica anual del ACAAI de este año muestran que la mayoría de las personas que piensan que tendrán una reacción alérgica, o que creen que han tenido una respuesta alérgica a la primera vacuna, pueden recibir todas las dosis de la vacuna de forma segura.
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que, aunque el 58 % de los encuestados informaron de que su médico de atención primaria (PCP) les habló sobre la incorporación temprana del cacahuate, solo el 40 % de los padres dijo haber recibido una recomendación de incorporar el cacahuate antes de los 11 meses de edad.
A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals Latinos with asthma were 4.6 times more likely than Blacks to develop asthma exacerbations (uncontrolled asthma) following COIVD-19, and 2.9 times more likely than whites.
A new study being presented at this year’s ACAAI Annual Scientific Meeting showed the majority of pregnant women with a penicillin allergy label who were tested were not allergic and could tolerate penicillin during labor.
A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals that although 58% of those surveyed reported their primary care physician discussed early peanut introduction, only 40% of the parents said they received a recommendation to introduce peanut by 11 months of age.
Two new studies being presented at this year’s ACAAI Annual Scientific Meeting show most people who think they will have an allergic reaction, or who believe they have had an allergic response to the first vaccine, can safely be fully vaccinated.
A new study being presented at this ACAAI Annual Scientific Meeting reveals that most young adults surveyed did not receive sufficient transition preparation from their pediatric asthma providers.
CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.
In a newly published study, researchers at the University of Maryland School of Medicine have detected antibodies primarily made in response to infections in the mucous membranes — in such areas as the lungs, intestines, or vagina — in study participants with malaria.
Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination. The study findings have been published in the Annals of Internal Medicine.
A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.
Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.
There is no evidence that Fauci knowingly gave false information when asked about the NIH funding of " gain-of-function research" when it comes to the coronavirus. In fact, the letter itself notes that the viruses used in the experiments are “decades removed from SARS-CoV-2 evolutionarily” and that they “could not have been the source of SARS-CoV-2.”
A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.
The contributors are Kazan Federal University, Kazan State Medical Academy, Thapar Institute of Engineering and Technology, and the University of Liverpool.
A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.
Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.
Scientists from RUDN, National Medical Research Centre for Hematology and Lomonosov Moscow State University have uncovered one of the possible pathogenetic mechanisms of the severe lymphopenia in patients with COVID-19. For the first time, they presented evidence of the possibility of direct infection of lymphocytes with SARS-CoV-2 virions.
Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published today in the Journal of Clinical Investigation.
In pregnant women who tested positive for SARS-CoV-2, the virus that causes COVID-19, male placentas demonstrated significantly higher levels of certain genes and proteins associated with increased immune activation compared with female placentas, according to a new study published in Science Translational Medicine.
THE antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.
Have you ever experienced a stressful time in your life and then caught a cold, or wondered why you feel sad and depressed when you’re sick? It turns out that it’s not all in your head.
Recent research spanning the fields of neuroscience and immunology suggests that when the brain senses a threat in the environment—whether it be physical, psychological, or social—it sends signals via a complex network of peripheral nerves that mobilize the immune system, readying it to protect us from injury.
New research has revealed that red blood cells function as critical immune sensors by binding cell-free DNA, called nucleic acid, present in the body’s circulation during sepsis and COVID-19, and that this DNA-binding capability triggers their removal from circulation, driving inflammation and anemia during severe illness and playing a much larger role in the immune system than previously thought. Scientists have long known that red blood cells, which are essential in delivering oxygen throughout the body, also interacted with the immune system, but didn’t know whether they directly altered inflammation, until now. The study, led by researchers at the Perelman School of Medicine at the University of Pennsylvania, was published today in Science Translational Medicine.
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine congratulates Treasurer Nancy Kopp on her five decades of public service, including since 2002, as the Maryland State Treasurer.
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in Cancer Cell in October.